Lysine-based polycation:heparin coacervate for controlled protein delivery.

Lysine-based polycation:heparin coacervate for controlled protein delivery.
复制标题

DOI:
10.1016/j.actbio.2013.09.012
复制
发表时间:
2014-01
期刊:
影响因子:
9.7
通讯作者:
Wang Y
Wang Y
中科院分区:
工程技术1区
文献类型:
--
作者:
Johnson NR;Ambe T;Wang Y

文献摘要

参考文献

被引文献

相似文献

聚合阳离子作为蛋白质和遗传物质的载体具有良好的潜力。然而,对释放速度的控制不力和安全问题目前限制了它们作为运载工具的使用。在这里,我们介绍了一种新的赖氨酸基聚阳离子,聚(乙烯赖氨酸天冬氨酸二甘油酯)(PELD),它具有很高的细胞相容性。PELD与生物聚阴离子肝素自组装成凝聚体,结合蛋白质,具有高负载效率。通过简单地改变PELD:肝素的比例,可以获得不同表面电荷的凝聚体,并导致模型蛋白牛血清白蛋白的不同释放谱。因此,凝聚电荷是控制释放速率和持续时间的直接手段。PELD凝聚体也可以快速吸附到多孔聚合物支架上,这表明了它在组织工程中的潜在应用。该凝聚体代表了一种安全可调的生物医学应用蛋白递送系统。
Polycations have good potential as carriers of proteins and genetic material. However, poor control over the release rate and safety issues currently limit their use as delivery vehicles. Here we introduce a new lysine-based polycation, poly(ethylene lysinylaspartate diglyceride) (PELD), which exhibits high cytocompatibility. PELD self-assembles with the biological polyanion heparin into a coacervate that incorporates proteins with high loading efficiency. Coacervates of varying surface charge were obtained by simple alteration of the PELD:heparin ratio and resulted in diverse release profiles of the model protein bovine serum albumin. Therefore, coacervate charge represents a direct means of control over release rate and duration. The PELD coacervate also rapidly adsorbed onto a porous polymeric scaffold, demonstrating potential use in tissue engineering applications. This coacervate represents a safe and tunable protein delivery system for biomedical applications.
DOI: 10.1016/s0168-3659(01)00547-8
发表时间: 2002-04-23
影响因子: 10.8
作者:
Ahn, CH;Chae, SY;Kim, SW
通讯作者: Kim, SW
DOI: 10.1021/bc00016a011
发表时间: 1992-07-01
影响因子: 4.7
作者:
TRUBETSKOY, VS;TORCHILIN, VP;HUANG, L
通讯作者: HUANG, L
DOI: 10.1371/journal.pone.0063075
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Johnson NR;Wang Y
通讯作者: Wang Y
DOI: 10.1016/s0168-3659(97)00174-0
发表时间: 1998-06-01
影响因子: 10.8
作者:
Choi, YH;Liu, F;Kim, SW
通讯作者: Kim, SW
DOI: 10.1038/sj.gt.3301052
发表时间: 2000-01-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Nguyen, HK;Lemieux, P;Kabanov, AV
通讯作者: Kabanov, AV